Fine particulate matter is associated with a broad spectrum of acute and chronic illness, such as lung cancer, chronic obstructive pulmonary disease (COPD) and cardiovascular diseases. Worldwide, it is estimated to cause about 16% of lung cancer deaths, 11% of COPD deaths, and more than 20% of ischaemic heart disease and stroke. Particulate matter pollution is an environmental health problem that affects people worldwide, but low- and middle-income countries disproportionately experience this burden.
LPG is a proven solution to one of the most pressing problems, facing and ever more urbanised world: air pollution. Whether in the streets of Shanghai, Lagos, London or Bogota, deteriorating air quality has a serious and global impact on our health.